Publications - IR Sant Pau

Search

01/06/2025 FACTORS ASSOCIATED WITH ACHIEVING REMISSION OR LOW DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING JANUS KINASE INHIBITOR TREATMENT

Martinez-Molina, C, Park, HS, Díaz-Torné, C, Vidal, S, Corominas, H. FACTORS ASSOCIATED WITH ACHIEVING REMISSION OR LOW DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING JANUS KINASE INHIBITOR TREATMENT. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B3700. PMID:. IF:20.600(Q1/1D).

01/06/2025 CLINICAL AND ULTRASOUND FEATURES OF A COHORT OF PSO PATIENTS WITHOUT MUSCULOSKELETAL SYMPTOMS: A PROSPECTIVE AND MULTICENTER STUDY

Azuaga, AB, Cuervo, A, Reina, D, Estrada, P, Soria, LM, Aparicio, M, Moreno, M, Arevalo, M, Laiz, A, Moya, P, Alascio, L, Riera, J, Scher, JU, Crespillo, JDDC, Ramirez, J. CLINICAL AND ULTRASOUND FEATURES OF A COHORT OF PSO PATIENTS WITHOUT MUSCULOSKELETAL SYMPTOMS: A PROSPECTIVE AND MULTICENTER STUDY. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B1990. PMID:. IF:20.600(Q1/1D).

01/06/2025 EVALUATION OF THE NEW CRITERIA FOR PROGRESSIVE PULMONARY FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS

Retuerto-Guerrero, M, Morales, CM, Santos, CS, Herránz, LS, Juan, J, Castellví, I, Alvarez, ED. EVALUATION OF THE NEW CRITERIA FOR PROGRESSIVE PULMONARY FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B1643. PMID:. IF:20.600(Q1/1D).

01/06/2025 COMPARATIVE ANALYSIS OF PROGRESSIVE PULMONARY FIBROSIS CRITERIA IN SYSTEMIC SCLEROSIS PATIENTS

Retuerto-Guerrero, M, Morales, CM, Santos, CS, Herránz, LS, Juan, J, Castellvi, I, Alvarez, ED. COMPARATIVE ANALYSIS OF PROGRESSIVE PULMONARY FIBROSIS CRITERIA IN SYSTEMIC SCLEROSIS PATIENTS. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B1597. PMID:. IF:20.600(Q1/1D).

01/06/2025 DISTINCTIVE CLINICAL TRAITS OF ANTICENTROMERE ANTIBODY-POSITIVE SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A MULTICENTER RETROSPECTIVE STUDY

Valera-Ribera, C, Alegre-Sancho, JJ, Castellvi, I, Ibanez, M, Garcia, FJN. DISTINCTIVE CLINICAL TRAITS OF ANTICENTROMERE ANTIBODY-POSITIVE SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A MULTICENTER RETROSPECTIVE STUDY. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B3437. PMID:. IF:20.600(Q1/1D).

01/06/2025 UNDERSTANDING THE IMPACT OF EMA/PRAC SAFETY RECOMMENDATIONS ON THE REAL-WORLD USE OF JAK INHIBITORS IN RA

Paños, HB, Saborit, MC, Lasanta, MAL, Lizarzaburu, MS, Ruiz-Esquide, V, Vilaseca, DR, Nack, A, Perez-Garcia, C, Bernardez, J, Guillen, AG, Aguilar, JR, Cuervo, A, Roc, MV, Gomez, CG, Mínguez, S, Novell, RM, Estrada, P, Martinez-Morillo, M, Grau, CP, Busquets-Perez, N, Park, HS, Gómez-Puerta, JA, Pérez, SH, Palau, NM, Sanmarti, R, Mateo, L, Diaz-Torne, C, Corominas, H, Alarcon, GS. UNDERSTANDING THE IMPACT OF EMA/PRAC SAFETY RECOMMENDATIONS ON THE REAL-WORLD USE OF JAK INHIBITORS IN RA. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B3117. PMID:. IF:20.600(Q1/1D).

01/06/2025 PROGNOSTIC VALUE OF HYPERURICEMIA IN DEVELOPING CARDIOVASCULAR EVENTS IN PATIENTS WITH CHRONIC INFLAMMATORY ARTHRITIS: A 10-YEAR PROSPECTIVE STUDY

Avilés, A, Plaza, Z, Sánchez-Alonso, F, Castañeda, S, Fernández-Gutiérrez, B, Diaz-Torne, C, Pilar, FU, González, OM, Gallego, JMS, Giner, E, Cid, AR, Gómez, AP, Nievas, GS, García, J, Juanatey, CG, Llorca, J, González-Gay, MA, Andrés, M. PROGNOSTIC VALUE OF HYPERURICEMIA IN DEVELOPING CARDIOVASCULAR EVENTS IN PATIENTS WITH CHRONIC INFLAMMATORY ARTHRITIS: A 10-YEAR PROSPECTIVE STUDY. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.A1239. PMID:. IF:20.600(Q1/1D).

01/06/2025 EFFECTIVENESS AND SAFETY OF JANUS KINASE INHIBITORS IN GIANT CELL ARTERITIS. REAL-WORLD CLINICAL PRACTICE STUDY AND LITERATURE REVIEW

López-Gutiérrez, F, Loricera, J, Tofade, T, Prieto-Peña, D, Romero-Yuste, S, De Miguel, E, Riveros-Frutos, A, Nuñez, DF, Ferraz-Amaro, I, Castañeda, S, Labrador-Sánchez, E, Maiz, O, Garcia, FJN, Galindez-Agirregoikoa, E, González, I, Urruticoechea-Arana, A, Calvo, AR, Moya, P, Unizony, S, Blanco, R. EFFECTIVENESS AND SAFETY OF JANUS KINASE INHIBITORS IN GIANT CELL ARTERITIS. REAL-WORLD CLINICAL PRACTICE STUDY AND LITERATURE REVIEW. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B2775. PMID:. IF:20.600(Q1/1D).

01/06/2025 EFFECTS OF ABATACEPT VERSUS HYDROXYCHLOROQUINE ON THE PROGRESSION TO RHEUMATOID ARTHRITIS IN PALINDROMIC RHEUMATISM: ATWO-YEAR MULTICENTER RANDOMIZED CLINICAL TRIAL. THE PALABA STUDY

Sanmarti, R, Perez-Garcia, C, de-Toro-Santos, FJ, Alarcon, GS, Escudero-Contreras, A, Cuervo, A, Graell, E, Reina, D, Binstock, EK, Corominas, H, Urionaguena-Onaindia, I, Lasanta, MAL, Alejandro, O, Gomez, MS, Frade-Sosa, B, Novell, RM, Polino, L, Ostiz, JAM, Oreiro, N, Blanco, FJ, Nadales, IP, Ortega-Castro, R, Busquets-Pérez, N, Gómez-Centeno, A, Camacho, O, Cros, JRR, Arciniegas, AMM, Llorente, JFG, Paños, HB, Prior-Español, A, Quiñones, SC, Cruceta, A, Bonfill, E, Gómez, GD, Fàbregas, AR, Maestre, LT, Gomara, MJ, Haro, I. EFFECTS OF ABATACEPT VERSUS HYDROXYCHLOROQUINE ON THE PROGRESSION TO RHEUMATOID ARTHRITIS IN PALINDROMIC RHEUMATISM: ATWO-YEAR MULTICENTER RANDOMIZED CLINICAL TRIAL. THE PALABA STUDY. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B938. PMID:. IF:20.600(Q1/1D).

01/06/2025 CLINICAL PRESENTATION OF IGG4-RELATED DISEASE. MULTICENTER STUDY AND LITERATURE REVIEW

López-Gutiérrez, F, Loricera, J, Calabuig, PM, Gil, JJF, González-Mazario, R, Hormigos, C, Freites, D, Laguna, MR, Moya, P, Gómez, ML, Corominas, H, Silva-Díaz, M, Arribas, GG, García-Aparicio, A, Font, J, Casafont-Solé, I, Castaneda, E, Argumánez, CM, Zas, R, Molina-Collada, J, Montero, SR, Melero-González, RB, Galindez-Agirregoikoa, E, Hernández, A, Pantoja, L, Abascal, IB, Jovani, V, Valls-Pascual, E, Mena-Vázquez, N, Gallego, A, Cabaleiro-Raña, N, González, RV, Andrés, M, Castañeda, S. CLINICAL PRESENTATION OF IGG4-RELATED DISEASE. MULTICENTER STUDY AND LITERATURE REVIEW. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B3669. PMID:. IF:20.600(Q1/1D).

01/06/2025 ACR/EULAR 2022 CLASSIFICATION CRITERIA COMPARED TO THE ACR 1990 CLASSIFICATION CRITERIA IN THE ARTESER REGISTRY OF GIANT CELL ARTERITIS

De Miguel, E, Dominguez-Alvaro, M, Hernández-Rodríguez, I, Silva-Díaz, M, Otano, JMB, Moya, P, Cabañas, MT, Angeles, VAN, Calvet, J, Casafont-Solé, I, Ivorra, JAR, Labrada-Arrabal, S, Vasques-Rocha, M, Iñiguez, CL, Dorta, AG, Fernández, CC, Villar, MA, Mas, AJ, Prado, FJ, Blanco, R. ACR/EULAR 2022 CLASSIFICATION CRITERIA COMPARED TO THE ACR 1990 CLASSIFICATION CRITERIA IN THE ARTESER REGISTRY OF GIANT CELL ARTERITIS. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B849. PMID:. IF:20.600(Q1/1D).

01/06/2025 VEXAS syndrome through a rheumatologist's lens: insights from a Spanish national cohort

García-Escudero, P, López-Gómez, M, López, BM, Dorta, AG, Frade-Sosa, B, Lizarzaburu, MS, Rúa-Figueroa, I, Fiallo, DV, de Miera, FJTS, Melero-Gonzalez, RB, Santos, DD, Miranda, JA, Belando, CG, Boselli, G, Boteanu, AL, Villalobos, L, Selaya, CC, Santos, CS, Alvarez, ED, Font, J, Alonso, ER, Araguás, ET, Merayo, EE, Rodriguez-Laguna, M, Monjo, I, Gómez, IV, Vela-Casasempere, P, Merino, C, Martínez, MI, Beriain, JAH, Ruiz-Román, A, Calvo-Alén, J. VEXAS syndrome through a rheumatologist's lens: insights from a Spanish national cohort. RHEUMATOLOGY. 2025; 64(6)DOI:10.1093/rheumatology/keaf094. PMID:39937690. IF:4.400(Q1/1D).

01/06/2025 INITIAL THERAPY IN SYSTEMIC SCLEROSIS-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION IMPROVES OUTCOMES ACROSS HAEMODYNAMIC THRESHOLDS AND RISK STRATIFICATION: INSIGHTS FROM THE EUSTAR DATABASE

Bjorkekjar, HJ, Bruni, C, Broch, K, Brunborg, C, Delgado, PC, Airo, P, Simeon-Aznar, CP, Truchetet, ME, Giollo, A, Balbir-Gurman, A, Martin, M, Denton, C, Gabrielli, A, Del Galdo, F, Vonk, M, Fretheim, H, Bitter, H, Midtvedt, O, Andreassen, A, Hoie, S, Tanaka, Y, Riemekasten, G, Mueller-Ladner, U, Matucci-Cerinic, M, Castellvi, I, Siegert, E, Hachulla, E, Molberg, O, Distler, O, Hoffmann-Vold, AM. INITIAL THERAPY IN SYSTEMIC SCLEROSIS-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION IMPROVES OUTCOMES ACROSS HAEMODYNAMIC THRESHOLDS AND RISK STRATIFICATION: INSIGHTS FROM THE EUSTAR DATABASE. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B1890. PMID:. IF:20.600(Q1/1D).

01/06/2025 TRANSITION IN BONE METABOLISM: INSIGHTS FROM A NATIONAL SURVEY IN SPAIN

Lopez, BPM, Lopez-Corbeto, M, Zavala, RG, Torrent, RB, Gonzalez-Fernandez, MI, Perello, CM, Sevilla-Perez, B, Fontana, NP, Pascual, AR, Ildefonso, MMS, Regueira, SM, Alcaniz, P, Gonzalez, JCN, Grana, J. TRANSITION IN BONE METABOLISM: INSIGHTS FROM A NATIONAL SURVEY IN SPAIN. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B1745. PMID:. IF:20.600(Q1/1D).

01/06/2025 COMPARISON OF BARICITINIB AND TOFACITINIB EFFECTIVENESS IN RHEUMATOID ARTHRITIS: INSIGHTS FROM A REAL-WORLD COHORT USING PROPENSITY SCORE ADJUSTMENTS

Lasanta, MAL, Saborit, MC, Panos, HB, Lizarzaburu, MS, Ruiz-Esquide, V, Vilaseca, DR, Nack, A, Perez-Garcia, C, Bernarde, J, Guillen, AG, Aguilar, JR, Cuervo, A, Valls, M, Gomez, CG, Minguez, S, Novell, RM, Alarcon, PE, Martinez-Morillo, M, Grau, CP, Busquets-Perez, N, Park, HS, Gomez-Puerta, JA, Perez, SH, Palau, NM, Sanmarti, R, Mateo-Soria, L, Diaz-Torne, C, Coromina, H, Alarcon, GS. COMPARISON OF BARICITINIB AND TOFACITINIB EFFECTIVENESS IN RHEUMATOID ARTHRITIS: INSIGHTS FROM A REAL-WORLD COHORT USING PROPENSITY SCORE ADJUSTMENTS. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B2477. PMID:. IF:20.600(Q1/1D).

01/06/2025 AMBISPECTIVE, MULTICENTER REGISTRY OF TREATMENT WITH ANIFROLUMAB IN REAL LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS FROM SPANISH RHEUMATOLOGY DEPARTMENTS (ANIFRO-REU): EFFICACY AND SAFETY AT 3-AND 6-MONTH FOLLOW-UP VISITS

Salman-Monte, TC, Carrion-Barberá, I, Triginer, L, Riveros-Frutos, A, Font, J, Garcia-Villanueva, MJ, Garrote-Corral, S, Galindo, M, Polo, CD, González, IA, Bernabéu, P, Casasempere, PV, Morales, CM, Alvarez, ED, Cortés-Hernández, J, Moreno, SS, Giráldez, CR, Gil, JJF, Hernández, A, Magallares, BP, Garcia, MMP, Cid, CMF, Hernández, S, Ros, I, García-Aparicio, A, Sala-Icardo, L, Gómez-Puerta, JA, Frade-Sosa, B, Garcia-Cirera, S, Bufort, MG, Martínez-Barrio, J, de Salazar, JRG, del Amo, ND, Fito-Manteca, C, Torrente-Segarra, V, Heredia, S, Brandy-Garcia, A, Lucea, ER, Zarrabeitia, LR, Urruticoechea-Arana, A, Pego-Reigosa, JM, Rúa-Figueroa, IJ. AMBISPECTIVE, MULTICENTER REGISTRY OF TREATMENT WITH ANIFROLUMAB IN REAL LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS FROM SPANISH RHEUMATOLOGY DEPARTMENTS (ANIFRO-REU): EFFICACY AND SAFETY AT 3-AND 6-MONTH FOLLOW-UP VISITS. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B1338. PMID:. IF:20.600(Q1/1D).

01/06/2025 A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis

Bjorkekjaer, HJ, Bruni, C, Broch, K, Brunborg, C, Carreira, PE, Airò, P, Simeón-Aznar, CP, Truchetet, ME, Giollo, A, Balbir-Gurman, A, Martin, M, Denton, CP, Gabrielli, A, Del Galdo, F, Vonk, MC, Fretheim, H, Bitter, H, Midtvedt,O, Andreassen, A, Hoie, S, Tanaka, Y, Riemekasten, G, Mueller-Ladner, U, Matucci-Cerinic, M, Castellví, I, Siegert, E, Hachulla, E, Molberg,O, Distler, O, Hoffmann-Vold, AM, EUSTAR Collaborators. A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis. RHEUMATOLOGY. 2025; 64(6)DOI:10.1093/rheumatology/keaf053. PMID:39878955. IF:4.400(Q1/1D).

01/06/2025 Induction of neoantigen-specific immune responses by VB10.NEO in combination with atezolizumab in heavily pretreated patients with advanced solid tumors: Final analysis of the phase 1b VB N-02 trial.

Ochsenreither, S, Anguera, G, Dieter, S, Trikalinos, N, Fu, SQ, Fernández, BC, Ferrandiz, AC, Kim, SY, Rodriguez, LM, Berg, KCG, Hassan, HIB, Rosholm, A, Fredriksen, AB. Induction of neoantigen-specific immune responses by VB10.NEO in combination with atezolizumab in heavily pretreated patients with advanced solid tumors: Final analysis of the phase 1b VB N-02 trial.. JOURNAL OF CLINICAL ONCOLOGY. 2025; 43(16_SUPPL)DOI:10.1200/JCO.2025.43.16_suppl.2639. PMID:. IF:41.900(Q1/1D).

01/06/2025 Molecular residual disease analysis of adjuvant osimertinib in resected EGFR-mutated stage IB-IIIA non-small-cell lung cancer

Herbst, RS, John, T, Grohé, C, Goldman, JW, Kato, T, Laktionov, K, Bonanno, L, Tiseo, M, Majem, M, Dómine, M, Ahn, MJ, Kowalski, DM, Pérol, M, Sriuranpong, V, Özgüroglu, M, Bhetariya, P, Markovets, A, Rukazenkov, Y, Muldoon, C, Robichaux, J, Hartmaier, R, Tsuboi, M, Wu, YL. Molecular residual disease analysis of adjuvant osimertinib in resected EGFR-mutated stage IB-IIIA non-small-cell lung cancer. NATURE MEDICINE. 2025; 31(6)DOI:10.1038/s41591-025-03577-y. PMID:40097663. IF:50.000(Q1/1D).

01/06/2025 Predictors of withdrawal of anticancer drug indications granted accelerated approval: a retrospective cohort study

Tibau, A, Cliff, ERS, Romano, A, Borrell, M, Molto, C, Kesselheim, AS. Predictors of withdrawal of anticancer drug indications granted accelerated approval: a retrospective cohort study. Eclinicalmedicine. 2025; 84DOI:10.1016/j.eclinm.2025.103088. PMID:40687736. IF:10.000(Q1/1D).

01/06/2025 Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia

Jiménez-Vicente, C, Arribas, I, Pomares, H, Ramil, G, Castaño-Diez, S, Pérez-Valencia, AI, Sturla, AL, López-Guerra, M, Martinez-Roca, A, Zugasti, I, Guijarro, F, Cortés-Bullich, A, Merchán, B, Triguero, A, Monge, I, Tuca, A, Oñate, G, Garrido, A, Sierra, J, Arnan, M, Esteve, J, Díaz-Beyá, M. Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia. HAEMATOLOGICA. 2025; 110(6)DOI:10.3324/haematol.2024.286589. PMID:39844754. IF:10.100(Q1/2D).

01/06/2025 Current advances and unmet needs in Alzheimer's disease trials for individuals with Down syndrome: Navigating new therapeutic frontiers

Barroeta, I, Videla, L, Carmona-Iragui, M, Fortea, J, Rafii, MS. Current advances and unmet needs in Alzheimer's disease trials for individuals with Down syndrome: Navigating new therapeutic frontiers. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70258. PMID:40528298. IF:11.100(Q1/1D).

01/06/2025 Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndrome

Sauer, M, Gomes, BF, Shahrouki, P, Lantero-Rodriguez, J, Montoliu-Gaya, L, Camporesi, E, Belbin, O, Alcolea, D, Kumar, A, Sharma, M, Singh, S, Brinkmalm, G, Gobom, J, Carmona-Iragui, M, Schöll, M, Janelidze, S, Deep, G, Blennow, K, Zetterberg, H, Brinkmalm, A, Lleó, A, Fortea, J, Hansson, O, Ashton, NJ, Nilsson, J. Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndrome. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70241. PMID:40522075. IF:11.100(Q1/1D).

01/06/2025 Bridging perspectives: The value of collaboration between Traditional Healing Practitioners and Medical Doctors in dementia research and care in South Africa

McGlinchey, E, Ranchod, K, Stroebel, R, Lusizi, B, Galvin, M, Kleinhans, AV, Fortea, J, Hoffman, J, Makanya, S. Bridging perspectives: The value of collaboration between Traditional Healing Practitioners and Medical Doctors in dementia research and care in South Africa. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70370. PMID:40566835. IF:11.100(Q1/1D).

01/06/2025 Adverse drug events associated with emergency departments visits

Ramos, JR, Perrín, RS, Martín, MAG, Clemente, YC, Díez, MA, Pinto, AD, Díaz, AS, Almela, AFD, Serrano, PS, Grande, ASL, Blanco, CC. Adverse drug events associated with emergency departments visits. EMERGENCIAS. 2025; 37(3)DOI:10.55633/s3me/025.2025. PMID:. IF:6.300(Q1/1D).

01/06/2025 Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview

Delaby, C, Ladang, A, Martinez-Yriarte, J, Zecca, C, Logroscino, G, Koertvelyessy, P, Tumani, H, Parchi, P, Quadrio, I, Hart, M, Olsen, DA, Alcolea, D, Blennow, K, Fortea, J, Lleo, A, Algeciras-Schimnich, A, Ayrignac, X, Bedel, A, Santos, GAA, Borelli, W, Bouaziz-Amar, E, Baldeiras, I, Bigot-Corbel, E, Bjerke, M, Perez, MC, Casoli, T, Chabrashvili, T, Chapman, MD, Cusato, J, Dursun, E, Fourier, A, Galimberti, D, Gezen-Ak, D, Gordon, BA, Gouju, J, Florez, SD, Sanchez, JH, Herwerth, M, Imperiale, D, Kaczorowski, F, Kasuga, K, Keshavan, A, Khalil, M, Kuhle, J, Leithner, C, Lewczuk, P, Letournel, F, Tsolaki, M, Giuffre, GM, Blanc, MC, Mroczko, B, Rodriguez, JEM, Musso, G, Kulczynska-Przybik, A, Nogueira, L, Paquet, C, Baiardi, S, Gaetani, L, Parnetti, L, Garay, RP, Poesen, K, Quillard-Muraine, M, Borja, ER, Schraen, S, Terracciano, D, Bachhuber, F, Halbgebauer, S, Tzartos, S, Tzartos, J, Unterwalder, N, Vermunt, L, Wellington, CL, Zetterberg, H, Teunissen, C, Lehmann, S. Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70343. PMID:40551293. IF:11.100(Q1/1D).

01/06/2025 Clinical-epidemiological aspects, hospitalization, and reconsultations in older patients with atrial fibrillation in emergency departments in Spain (EDEN-35 study): sex-disaggregated analysis

Coll-Vinent, B, Hernández, NM, Marco, NC, Boixeda, C, Rodríguez, JJ, Alquézar-Arbé, A, Alonso, CF, Burillo-Putze, G, Montero-Pérez, FJ, del Castillo, JG, Miró, O. Clinical-epidemiological aspects, hospitalization, and reconsultations in older patients with atrial fibrillation in emergency departments in Spain (EDEN-35 study): sex-disaggregated analysis. EMERGENCIAS. 2025; 37(3)DOI:10.55633/s3me/035.2025. PMID:40531120. IF:6.300(Q1/1D).

01/06/2025 Discrepancies in assessing intellectual disability levels in adults with Down syndrome: Implications for dementia diagnosis

Soriano, LD, Sandkühler, K, Videla, L, Benejam, B, Carmona-Iragui, M, Wlasich, E, Kustermann, J, Barroeta, I, Vaqué-Alcázar, L, Rodríguez-Baz, I, Bejanin, A, Fernández, S, Arranz, J, Arriola-Infante, JE, Maure-Blesa, L, Juan, AS, Nübling, G, Wagemann, O, Stockbauer, A, Hassenstab, J, Levin, J, Fortea, J. Discrepancies in assessing intellectual disability levels in adults with Down syndrome: Implications for dementia diagnosis. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70307. PMID:40528393. IF:11.100(Q1/1D).

01/06/2025 Down syndrome in Africa: Challenges, opportunities, and future directions

McGlinchey, E, Tewolde, S, He, AMD, Fortea, J, Mbakile-Mahlanza, L, Tefera, A, Epenge, E, Hassenstab, J, Jaeck, A, Ranchod, K, El-Jaafary, S, Levin, J, Salama, M, Rubenstein, E, Akinyemi, R, Akinyemi, T, Farombi, T, Lawlor, B, Ikanga, J, Ashton, NJ, Stout, S, Balls-Berry, J, Kleinhans, AV, Maina, R, Merali, Z. Down syndrome in Africa: Challenges, opportunities, and future directions. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70388. PMID:40538002. IF:11.100(Q1/1D).

01/06/2025 The history of Down syndrome-associated Alzheimer's disease; past, present, and future

Maure-Blesa, L, Carmona-Iragui, M, Lott, I, Head, E, Wisniewski, T, Rafii, MS, Espinosa, J, Flórez, J, Mobley, WC, Holland, A, Strydom, A, Zaman, S, Fortea, J. The history of Down syndrome-associated Alzheimer's disease; past, present, and future. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70158. PMID:40469048. IF:11.100(Q1/1D).

01/06/2025 Cargo of small extracellular vesicles from neuronal origin shows progression of dementia in individuals with Down syndrome

Ledreux, A, Carmona-Iragui, M, Videla, L, Benejam, B, Barroeta, I, Lleó, A, Alcolea, D, Fortea, J. Cargo of small extracellular vesicles from neuronal origin shows progression of dementia in individuals with Down syndrome. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70380. PMID:40524460. IF:11.100(Q1/1D).

01/06/2025 Diagnostic performance of plasma Aß42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center study

Doecke, JD, Bellomo, G, Vermunt, L, Alcolea, D, Halbgebauer, S, In't Veld, S, Mattsson-Carlgren, N, Veverova, K, Fowler, CJ, Boonkamp, L, Houtkamp, IM, Koel-Simmerlink, M, Verberk, IMW, Gaetani, L, Toja, A, Wojdala, AL, Fortea, J, Pijnenburg, Y, Lemstra, A, van der Flier, W, Hort, J, Otto, M, Hansson, O, Parnetti, L, Masters, CL, Lleó, A, González-Escalante, A, Contador, J, Suárez-Calvet, M, Fernández-Lebrero, A, Puig-Pijoan, A, Ortiz-Romero, P, Jimenez-Moyano, E, Minguillón, C, del Campo, M, Teunissen, C. Diagnostic performance of plasma Aß42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center study. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.14573. PMID:40551285. IF:11.100(Q1/1D).

01/06/2025 Validation of a biomarker-based mortality score for cardiogenic shock patients: Comparison with a clinical risk score

Hynninen, E, Tolppanen, H, Rivas-Lasarte, M, Tarvasmaeki, T, Harjola, VP, Deniau, B, Hongisto, M, Jankowska, EA, Jurkko, R, Jaentti, T, Kataja, A, Mebazaa, A, Sabell, T, Sionis, A, Lassus, J. Validation of a biomarker-based mortality score for cardiogenic shock patients: Comparison with a clinical risk score. ESC Heart Failure. 2025; 12(3)DOI:10.1002/ehf2.15234. PMID:39895206. IF:3.700(Q1/3D).

01/06/2025 Sex and clinical outcomes in new-onset heart failure

Vicent, L, García-Cosio, MD, Amigo, JS, Guerra, JM, Dolz, LM, Farré-López, N, Segovia-Cubero, J, Crespo-Leiro, MG, Carrasquer, A, Trillo, AG, Villacastin, JP, Matute-Blanco, L, Martínez-Sellés, M. Sex and clinical outcomes in new-onset heart failure. INTERNATIONAL JOURNAL OF CARDIOLOGY. 2025; 428DOI:10.1016/j.ijcard.2025.133092. PMID:40037478. IF:3.200(Q2/3D).

01/06/2025 Alpha-synuclein co-pathology in Down syndrome-associated Alzheimer's disease

Bernhardt, AM, Rodríguez-Baz, I, Aldecoa, I, Arranz, J, Arriola-Infante, JE, Maure-Blesa, L, Carmona-Iragui, M, Longen, S, Trossbach, SV, Giese, A, Matthias, T, Benejam, B, Videla, L, Soriano, LD, Barroeta, I, Sanjuan, A, Fernandez, S, Vaqué-Alcázar, L, Aranha, MR, Morcillo-Nieto, AO, Nübling, G, Wagemann, O, Stockbauer, A, Tondo, M, Bejanin, A, Lleó, A, Alcolea, D, Molina-Porcel, L, Fortea, J, Levin, J. Alpha-synuclein co-pathology in Down syndrome-associated Alzheimer's disease. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70342. PMID:40528443. IF:11.100(Q1/1D).

01/06/2025 Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey Study

Ukashi, O, Amiot, A, Laharie, D, Menchen, L, Gutierrez, A, Fernandes, S, Pessarelli, T, Correia, F, Gonzalez-Munoza, C, Lopez-Cardona, J, Calabrese, G, Ferreiro-Iglesias, R, Tamir-Degabli, N, Dussias, NK, Mousa, A, Oliveira, R, Richard, N, Veisman, I, Sharif, K, Ben-Horin, S, Soutullo-Castineiras, C, Dragoni, G, Rotulo, S, Favale, A, Calmejane, L, Bazin, T, Elosua, A, Lopes, S, Felice, C, Mauriz, V, Rodrigues, IC, Jougon, J, Botto, I, de Sousa, HT, Bertani, L, Abadia, PR, De Bernardi, A, Zabana, Y, Serra-Ruiz, X, Viola, A, Acosta, MBD, Yanai, H, Armuzzi, A, Magro, F, Kopylov, U. Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey Study. United European Gastroenterology Journal. 2025; 13(5)DOI:10.1002/ueg2.12757. PMID:39825768. IF:6.700(Q1/2D).

01/06/2025 The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discovery

Videla, L, Benejam, B, Barroeta, I, Fernandez, S, Altuna, M, Arranz, J, Rodríguez-Baz, I, Arriola-Infante, JE, Maure-Blesa, L, Soriano, LD, Illán-Gala, I, Estellés, T, Sanjuan, A, Vaqué-Alcázar, L, Aranha, MR, Morcillo-Nieto, AO, Zsadanyi, SE, Franquesa-Mullerat, M, Valldeneu, S, Sánchez-Saudinós, MB, Padilla, C, Carreras, M, Lorente, O, Valle-Tamayo, N, Sánchez-Aced, E, Dols-Icardo, O, Sirisi, S, Muñoz, L, Torres, S, El Bennadi, SE, Sánchez, O, Garzón, D, Ribas, L, Elbachiri, S, Mota, C, Tondo, M, Camacho, V, Giménez, S, Delaby, C, Belbin, O, Iulita, MF, Montal, V, Pegueroles, J, Vilaplana, E, Clarimon, J, Gonzalez-Ortiz, S, Molina-Porcel, L, Aldecoa, I, Alcolea, D, Bejanin, A, Videla, S, Blesa, R, Lleo, A, Carmona-Iragui, M, Fortea, J. The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discovery. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70259. PMID:40528282. IF:11.100(Q1/1D).

01/06/2025 Protective ileostomy creation after anterior resection of the rectum (PICARR): a decision-making exploring international survey

Balla, A, Saraceno, F, Rullo, M, Morales-Conde, S, Soler, EMT, Di Saverio, S, Guerrieri, M, Lepiane, P, Di Lorenzo, N, Adamina, M, Alarcon, I, Arezzo, A, Rodriguez, JB, Boni, L, Biondo, S, Carrano, FM, Chand, M, Jenkins, JT, Davies, J, Rivilla, SD, Delrio, P, Elmore, U, Espin-Basany, E, Fichera, A, Lorente, BF, Francis, N, Ruiz, MG, Hahnloser, D, Licardie, E, Martinez, C, Ortenzi, M, Panis, Y, Idoate, CP, Paganini, AM, Pera, M, Perinotti, R, Popowich, DA, Rockall, T, Rosati, R, Sartori, A, Scoglio, D, Shalaby, M, Fernandez, VS, Smart, NJ, Spinelli, A, Sylla, P, Tanis, PJ, Hernandez, JV, Wexner, SD, Sileri, P. Protective ileostomy creation after anterior resection of the rectum (PICARR): a decision-making exploring international survey. Updates in Surgery. 2025; 77(3)DOI:10.1007/s13304-025-02111-6. PMID:40121358. IF:2.200(Q2/4D).

01/06/2025 DOWN SYNDROME RESULTS IN AN AMPLIFIED INTERFERON RESPONSE TO AMYLOID-ß THAT IS ASSOCIATED WITH PRODROMAL ALZHEIMER'S DISEASE

Mumford, P, Farrell, C, Kammuri, F, Cannavo, C, Banks, G, Yaman, U, Yu, LJL, Stewart, M, Iulita, MF, Wells, S, Salih, D, Belbin, O, Carmona-Iragui, M, Fortea, J, Wiseman, F. DOWN SYNDROME RESULTS IN AN AMPLIFIED INTERFERON RESPONSE TO AMYLOID-ß THAT IS ASSOCIATED WITH PRODROMAL ALZHEIMER'S DISEASE. GLIA. 2025; 73DOI:. PMID:. IF:5.100(Q1/2D).

01/06/2025 Comprehensive approach to medication-related problems leading to emergency department visits from a gender perspective

Marín-Barcena, C, Puig-Campmany, M, Ruiz-Ramos, J, Carazo-Díaz, C, Vicente-Romero, J, Juanes-Borrego, A. Comprehensive approach to medication-related problems leading to emergency department visits from a gender perspective. EMERGENCIAS. 2025; 37(3)DOI:10.55633/s3me/026.2025. PMID:40531118. IF:6.300(Q1/1D).

01/06/2025 Characterization of the Cystic Phenotype Associated with Monoallelic ALG8 and ALG9 Pathogenic Variants

Jawaid, T, Elbarougy, DE, Lavu, S, Buia, G, Senum, SR, Olinger, E, Yang, HN, Mcdonnell, SK, Bublitz, JT, Ma, J, Audrézet, MP, Madsen, CD, Schauer, RS, Baker, TA, Gregory, AV, Orr, SE, Barroso-Gil, M, Neatu, R, Joli, G, Dahl, NK, Kline, TL, Gillion, V, Dahan, K, Jouret, F, Perrone, RD, Steinman, TI, Peters, DJM, Gitomer, BY, Watnick, TJ, Coto, E, Chebib, FT, Hogan, MC, Olson, JE, Larson, NB, Ars, E, Halbritter, J, Demoulin, N, Torres, VE, Sayer, JA, Cornec-Le Gall, E, Harris, PC. Characterization of the Cystic Phenotype Associated with Monoallelic ALG8 and ALG9 Pathogenic Variants. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2025; 36(6)DOI:10.1681/ASN.0000000613. PMID:39899384. IF:9.400(Q1/1D).

01/06/2025 Bimekizumab clinical efficacy in impactful body regions and health-related quality of life in patients with plaque psoriasis: Data from four phase 3/3b comparator-controlled trial periods

Smith, A, Armstrong, AW, Elewski, B, Rich, P, Augustin, M, Carrascosa, JM, Vender, R, Lambert, J, Pinto, JML, Hoepken, B, Kavanagh, S, Puig, L. Bimekizumab clinical efficacy in impactful body regions and health-related quality of life in patients with plaque psoriasis: Data from four phase 3/3b comparator-controlled trial periods. AUSTRALASIAN JOURNAL OF DERMATOLOGY. 2025; 66DOI:. PMID:. IF:1.800(Q3/6D).

30/05/2025 SARS-CoV-2 infection of human cortical cells is influenced by the interaction between aneuploidy and biological sex: insights from a Down syndrome in vitro model

Lioudyno, MI, Sevrioukov, EA, Olivarria, GM, Hitchcock, L, Javonillo, DI, Campos, SM, Rivera, I, Wright, ST, Head, E, Fortea, J, Wisniewski, T, Cuello, AC, Do Carmo, S, Lane, TE, Busciglio, J. SARS-CoV-2 infection of human cortical cells is influenced by the interaction between aneuploidy and biological sex: insights from a Down syndrome in vitro model. ACTA NEUROPATHOLOGICA. 2025; 149(1)DOI:10.1007/s00401-025-02895-2. PMID:40445428. IF:9.300(Q1/1D).

29/05/2025 Tuberculosis household contact tracing in children: axes of inequality, Barcelona 2003-2022

Prieto-García, R, Millet, JP, Soriano-Arandes, A, Espiau, M, Broto, C, Ronda, M, López, N, Noguera-Julian, A, Corcoll, EM, Jimenez, CD, Samsó, MR, Arroita, MIM, Valencia, JEO, Rebollo, CG, Viván, PS, Gibert, CR. Tuberculosis household contact tracing in children: axes of inequality, Barcelona 2003-2022. Frontiers in Public Health. 2025; 13DOI:10.3389/fpubh.2025.1591552. PMID:40510584. IF:3.400(Q1/2D).

29/05/2025 Muscle dysfunction is associated with poor quality of life in long-term controlled patients with acromegaly

Martel-Duguech, L, Bascuñana, H, Cuartero, J, Webb, SM, Valassi, E. Muscle dysfunction is associated with poor quality of life in long-term controlled patients with acromegaly. Pituitary. 2025; 28(3)DOI:10.1007/s11102-025-01539-8. PMID:40442526. IF:3.400(Q2/4D).

27/05/2025 Novel Experimental Dietary Supplementations to Combat Metabolic Alterations in Diabetes

Rossell, J, Julve, J. Novel Experimental Dietary Supplementations to Combat Metabolic Alterations in Diabetes. Nutrients. 2025; 17(11)DOI:10.3390/nu17111816. PMID:40507085. IF:5.000(Q1/2D).

26/05/2025 Educational interventions and contextual factors for optimising antibiotic prescription in paediatric uncomplicated acute respiratory tract infections in primary care: scoping review of reviews

Elizondo-Alzola, U, Rocha, C, Leache, L, León-García, M, Saiz, LC, Solà, I, Montesinos-Guevara, C, Meade, AG, Boldú, A, Bolibar, I, Niño-de-Guzmán, E, Alonso-Coello, P. Educational interventions and contextual factors for optimising antibiotic prescription in paediatric uncomplicated acute respiratory tract infections in primary care: scoping review of reviews. BMC Pediatrics. 2025; 25(1)DOI:10.1186/s12887-025-05688-4. PMID:40420306. IF:2.000(Q2/4D).

26/05/2025 Socioeconomic characteristics, health and wellbeing of nonbinary adolescents in a Southern European City

Artazcoz, L, Carrere, J, Pérez, K, Sánchez-Ledesma, E, Serral, G, López, MJ. Socioeconomic characteristics, health and wellbeing of nonbinary adolescents in a Southern European City. BMC PUBLIC HEALTH. 2025; 25(1)DOI:10.1186/s12889-025-23080-w. PMID:40420040. IF:3.600(Q1/2D).

24/05/2025 Regulatory asymmetry in Alzheimer's disease care

Fortea, J, Boban, M, Engelborghs, S, Frederiksen, KS, Hort, J, Kennelly, S, Kramberger, MG, Mehrabian, S, Plantone, D, Paquet, C, Santana, I, Scarmeas, N, Solje, E, Spiru, L, Sutovsky, S, Vijverberg, EGB, Winblad, B, Jessen, F. Regulatory asymmetry in Alzheimer's disease care. LANCET. 2025; 405(10492)DOI:10.1016/S0140-6736(25)00907-9. PMID:40381642. IF:88.500(Q1/1D).

23/05/2025 Risk factors associated with low bone mineral density and childhood osteoporosis in a population undergoing skeletal growth: a cross-sectional analytic study

Magallares, B, Cerdá, D, Betancourt, J, Fraga, G, Park, H, Codes-Méndez, H, Quesada-Masachs, E, López-Corbeto, M, Torrent, M, Marín, A, Herrera, S, Gich, I, Boronat, S, Casademont, J, Corominas, H, Malouf, J. Risk factors associated with low bone mineral density and childhood osteoporosis in a population undergoing skeletal growth: a cross-sectional analytic study. Frontiers in Endocrinology. 2025; 16DOI:10.3389/fendo.2025.1587985. PMID:40487764. IF:4.600(Q1/3D).

21/05/2025 URINARY PROTEOMIC ANALYSIS PROVIDES DIFFERENT PATTERNS BETWEEN LUPUS PATIENTS WITH AND WITHOUT NEPHRITIS: RESULTS OF A MULTICENTER STUDY IN 124 PATIENTS

Lucea, ER, García, NAR, Inchaurbe, A, Alén, JC, Aurrecoechea, E, Sola, AD, Zarrabeitia, LR, Diaz, M, Galindez, E, Fernández, O, Torre, I, Exposito, R, Allande, MJ, Abad-Plou, E, Alvarez, LV, Enjuanes, M, Gonzalez, G, Gonzalez, M, López, L, Barahona, E, Martínez, D, Alvarez, J, García-Vivar, ML. URINARY PROTEOMIC ANALYSIS PROVIDES DIFFERENT PATTERNS BETWEEN LUPUS PATIENTS WITH AND WITHOUT NEPHRITIS: RESULTS OF A MULTICENTER STUDY IN 124 PATIENTS. JOURNAL OF RHEUMATOLOGY. 2025; 52DOI:. PMID:. IF:3.400(Q2/3D).

21/05/2025 Cardiovascular disease in women with type 1 diabetes: a narrative review and insights from a population-based cohort analysis

Mesa, A, Franch-Nadal, J, Navas, E, Mauricio, D. Cardiovascular disease in women with type 1 diabetes: a narrative review and insights from a population-based cohort analysis. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02791-9. PMID:40399939. IF:10.600(Q1/1D).

21/05/2025 TRIPLE THERAPY WITH BELIMUMAB IN PROLIFERATIVE LUPUS NEPHRITIS: REAL-WORLD EFFICACY AND GLUCOCORTICOID-SPARING EFFECTS

Vidal-Montal, P, Fabregat, A, Heredia, S, Bernardez, J, Magallares, BP, Gómez-Puerta, J, Frade-Sosa, B, Nolla, JM, Narváez, J. TRIPLE THERAPY WITH BELIMUMAB IN PROLIFERATIVE LUPUS NEPHRITIS: REAL-WORLD EFFICACY AND GLUCOCORTICOID-SPARING EFFECTS. JOURNAL OF RHEUMATOLOGY. 2025; 52DOI:. PMID:. IF:3.400(Q2/3D).

20/05/2025 In Vitro Immune Response of Mononuclear Cells to Multidrug-Resistant Escherichia coli

Cuyàs, B, Cantó, E, Sanchez-Ardid, E, Miró, E, Alvarado-Tapias, E, Román, E, Poca, M, Navarro, F, Ferrero-Gregori, A, Escorsell, MA, Vidal, S, Soriano, G. In Vitro Immune Response of Mononuclear Cells to Multidrug-Resistant Escherichia coli. Microorganisms. 2025; 13(5)DOI:10.3390/microorganisms13051164. PMID:40431335. IF:4.200(Q2/3D).

15/05/2025 25-year follow-up on marked ventricular repolarization abnormalities in athletes: Long-term outcomes and cardiovascular prognosis

Salido, M, Moliner-Abós, C, Zoratti, L, Puig, T, Carreras-Costa, F, Serra-Grima, R. 25-year follow-up on marked ventricular repolarization abnormalities in athletes: Long-term outcomes and cardiovascular prognosis. INTERNATIONAL JOURNAL OF CARDIOLOGY. 2025; 427DOI:10.1016/j.ijcard.2025.133060. PMID:40010514. IF:3.200(Q2/3D).

15/05/2025 Frameworks to support evidence-informed decision-making in public health and infectious disease prevention and control: a scoping review

Song, Y, Bracchiglione, J, Meneses-Echávez, J, Gomes, HD, Albiger, B, Solà, I, Rigau, D, Alonso-Coello, P. Frameworks to support evidence-informed decision-making in public health and infectious disease prevention and control: a scoping review. Eurosurveillance. 2025; 30(19)DOI:10.2807/1560-7917.ES.2025.30.19.2400185. PMID:40376818. IF:7.800(Q1/1D).

15/05/2025 Users' experience of frameworks to support evidence-informed decision-making in public health: a scoping review

Bracchiglione, J, Song, Y, Meneses-Echávez, JF, Gomes, HD, Albiger, B, Solà, I, Rigau, D, Alonso-Coello, P. Users' experience of frameworks to support evidence-informed decision-making in public health: a scoping review. Eurosurveillance. 2025; 30(19)DOI:10.2807/1560-7917.ES.2025.30.19.2400184. PMID:40376821. IF:7.800(Q1/1D).

15/05/2025 One-Year Recurrent Tricuspid Regurgitation After Successful Transcatheter Edge to Edge Repair: The TRI-SPA Registry

Echarte-Morales, J, Cepas-Guillén, P, Arzamendi, D, Moñivas, V, Carrasco-Chinchilla, F, Pan, M, Nombela-Franco, L, Pascual, I, Benito-González, T, Pérez, R, Gómez-Blázquez, I, Amat-Santos, IJ, Cruz-González, I, Sánchez-Recalde, A, Caneiro-Queija, B, Alvarez, ABC, Barreiro-Pérez, M, Sanchis, L, Li, CH, del Trigo, M, Martínez-carmona, JD, Mesa, D, Jiménez, P, Avanzas, P, Freixa, X, Estévez-Loureiro, R. One-Year Recurrent Tricuspid Regurgitation After Successful Transcatheter Edge to Edge Repair: The TRI-SPA Registry. AMERICAN JOURNAL OF CARDIOLOGY. 2025; 243DOI:10.1016/j.amjcard.2025.02.010. PMID:39984153. IF:2.100(Q3/6D).

15/05/2025 A deep attention-based encoder for the prediction of type 2 diabetes longitudinal outcomes from routinely collected health care data

Manzini, E, Vlacho, B, Franch-Nadal, J, Escudero, J, Génova, A, Reixach, E, Andrés, E, Pizarro, I, Mauricio, D, Perera-Lluna, A. A deep attention-based encoder for the prediction of type 2 diabetes longitudinal outcomes from routinely collected health care data. EXPERT SYSTEMS WITH APPLICATIONS. 2025; 274DOI:10.1016/j.eswa.2025.126876. PMID:. IF:7.500(Q1/1D).

14/05/2025 Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patients diagnosed with acute myeloid leukemia: validation of the ELN-2021 MRD recommendations

Jimenez-Vicente, C, Cardus, A, Castaño-Diez, S, Ramil, G, Garcia-Avila, S, Gomez-Perez, L, Esteban, D, Arribas, I, Sturla, AL, Lopez-Guerra, M, Martinez-Roca, A, Cortes-Bullich, A, Perez-Valencia, AI, Zugasti, I, Monge, I, Carcelero, E, Vall-Llovera, F, Vives, S, Sierra, J, Nomdedeu, J, Oñate, G, Garrido, A, Pratcorona, M, Pomares, H, Arnan, M, Guijarro, F, Diaz-Beya, M, Esteve, J. Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patients diagnosed with acute myeloid leukemia: validation of the ELN-2021 MRD recommendations. Blood Cancer Journal. 2025; 15(1)DOI:10.1038/s41408-025-01298-6. PMID:40368916. IF:11.600(Q1/1D).